Comparing cholesterol targets after heart stent placement
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial compares two ways of guiding cholesterol-lowering treatment in people who have had a heart stent placed. It aims to find which method helps lower heart risks more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had a heart stent placed to open a blocked artery
- You are willing to join the study and sign a consent form
- You do not have serious liver disease
- You can take cholesterol-lowering medications (statins)
- You are expected to live at least one more year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different LDL cholesterol targets to find the best level for people at very high risk after a heart stent procedure. It tests whether aiming for a lower cholesterol goal improves outcomes.
This trial studies how to lower “bad” cholesterol (LDL) in people age 75 and older who have already had heart, brain, or leg/blood-vessel problems from blocked arteries. The goal is to see if the approach helps prevent further cardiovascular events (like heart attack or stroke).
This study compares different combinations of antiplatelet (blood-thinning for the stent) and cholesterol-lowering (statin) medicines after stent placement for a heart attack or unstable angina. The goal is to find the best way to prevent future heart problems and improve outcomes.
This trial looks at whether stronger cholesterol-lowering medicine can reduce the risk of future heart problems in people who already have a stent. It focuses on people who still have other mildly narrowed spots in their arteries.
This trial tests whether a single dose of a cholesterol-lowering drug called a PCSK9 inhibitor can improve heart outcomes after a stent procedure. If you recently had a stent and the imaging showed significant plaque, this may help reduce future risks.
This trial compares two very low LDL-cholesterol targets (below 1.0 vs 1.0-1.39 mmol/L) using extra medications (PCSK9 inhibitors) to see which is safer and better for people at extremely high risk of heart attacks or strokes.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.